Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 12.38% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
Mangoceuticals
MGRX
$9.56M
| $47.1K | ﹤0.01% |
+31,000
| New | +$58.2K |
|
|
GRO
3402
Brazil Potash Corp
GRO
$125M
| $46.6K | ﹤0.01% |
+34,300
| New | +$70.4K |
|
3403
Milestone Scientific
MLSS
$35.3M
| $46.6K | ﹤0.01% |
73,197
-4,559
| -6% | -$4.18K |
|
|
CASI
3404
DELISTED
CASI Pharmaceuticals
CASI
| $46.3K | ﹤0.01% |
39,200
+300
| +0.8% | +$550 |
|
3405
Verrica Pharmaceuticals
VRCA
$89.7M
| $46.2K | ﹤0.01% |
+8,720
| New | +$46.9K |
|
|
ZSTK
3406
ZeroStack Corp
ZSTK
$3.69M
| $46.2K | ﹤0.01% |
2,041
-62
| -3% | -$1.49K |
|
3407
Nexalin Technology
NXL
$7.44M
| $45.8K | ﹤0.01% |
+46,344
| New | +$65.1K |
|
3408
Acurx Pharmaceuticals
ACXP
$6.19M
| $44.8K | ﹤0.01% |
4,389
+3,059
| +230% | +$24.6K |
|
3409
Enveric Biosciences
ENVB
$6.32M
| $44.8K | ﹤0.01% |
+3,084
| New | +$46.7K |
|
3410
Nephros
NEPH
$36.8M
| $44.6K | ﹤0.01% |
+10,900
| New | +$29.1K |
|
3411
Wetouch Technology
WETH
$14M
| $44.1K | ﹤0.01% |
46,400
+8,600
| +23% | +$8.98K |
|
3412
TOP Financial Group
TOP
$255M
| $43.6K | ﹤0.01% |
35,600
+5,700
| +19% | +$6.96K |
|
3413
Nuvation Bio
NUVB
$2.2B
| $43.1K | ﹤0.01% |
22,100
-422,000
| -95% | -$879K |
|
|
HYFT
3414
MindWalk Holdings
HYFT
$60.6M
| $42.9K | ﹤0.01% |
40,480
+11,080
| +38% | +$6.34K |
|
|
ORIO
3415
Orion Digital Corp
ORIO
$15.4M
| $42.2K | ﹤0.01% |
33,500
-22,379
| -40% | -$25.4K |
|
3416
SunCar Technology Group
SDA
$77.2M
| $42.1K | ﹤0.01% |
+16,500
| New | +$47.1K |
|
3417
enGene Therapeutics
ENGN
$120M
| $41.5K | ﹤0.01% |
+11,400
| New | +$42.8K |
|
|
BEDU
3418
DELISTED
Bright Scholar Education Holdings
BEDU
| $41.1K | ﹤0.01% |
23,225
-200
| -0.9% | -$338 |
|
|
GXAI
3419
Gaxos.ai
GXAI
$8.06M
| $39.4K | ﹤0.01% |
+27,963
| New | +$35.2K |
|
3420
BranchOut Food
BOF
$59.9M
| $38.1K | ﹤0.01% |
15,683
-19,917
| -56% | -$40.3K |
|
3421
Dolphin Entertainment
DLPN
$13.3M
| $38.1K | ﹤0.01% |
33,100
+2,100
| +7% | +$2.26K |
|
3422
Tigo Energy
TYGO
$145M
| $37.9K | ﹤0.01% |
+29,712
| New | +$28.9K |
|
|
UBX
3423
DELISTED
Unity Biotechnology
UBX
| $37.8K | ﹤0.01% |
98,311
+4,100
| +4% | +$3.51K |
|
3424
Tandy Leather Factory
TLF
$19.3M
| $37.4K | ﹤0.01% |
12,100
-5,500
| -31% | -$16.2K |
|
|
TRIB
3425
Trinity Biotech
TRIB
$7.83M
| $37K | ﹤0.01% |
1,899
-657
| -26% | -$13.2K |
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.